key: cord-0723975-xhh2n6w7
authors: David, Adamson; Zev, Rosenwaks; Van Der Spuy, Zephne; Diaz Yamal, Ivonne
title: Reproductive health paradigms in times of COVID‐19
date: 2020-06-14
journal: Int J Gynaecol Obstet
DOI: 10.1002/ijgo.13231
sha: 271b0b0207f541f3fc86c0ee118042cefa9462d5
doc_id: 723975
cord_uid: xhh2n6w7

For the past several months, we have witnessed one of the greatest global health challenges experienced by humankind. This unprecedented COVID-19 viral pandemic, characterized by its enigmatic nature and bewildering spread, respects no borders and has nearly paralyzed healthcare systems throughout the world. Indeed, in the absence of specific, proven medical interventions, healthcare systems have been overwhelmed, thus limiting their ability to treat patients with non-emergent medical conditions and those awaiting elective procedures. Although it is beyond the scope of this editorial to discuss what constitutes a necessary or elective procedure, this radical change in medical practice has had an enormous impact on discontinuation of fertility care services, especially the assisted reproductive technologies (ART). It is eminently clear that reducing or discontinuing elective procedures and essential ART treatments was crucial not only to enable hospitals and medical facilities to manage (or to treat) the explosive rise in SARS-CoV-2 patients, but also to reduce disease transmission vis-à-vis various mitigating strategies-especially individual isolation and social distancing, strategies utilized effectively in China and Italy.

For the past several months, we have witnessed one of the greatest global health challenges experienced by humankind. This unprecedented COVID-19 viral pandemic, characterized by its enigmatic nature and bewildering spread, respects no borders and has nearly paralyzed healthcare systems throughout the world. Indeed, in the absence of specific, proven medical interventions, healthcare systems have been overwhelmed, thus limiting their ability to treat patients with non-emergent medical conditions and those awaiting elective procedures. Although it is beyond the scope of this editorial to discuss what constitutes a necessary or elective procedure, this radical change in medical practice has had an enormous impact on discontinuation of fertility care services, especially the assisted reproductive technologies (ART). It is eminently clear that reducing or discontinuing elective procedures and essential ART treatments was crucial not only to enable hospitals and medical facilities to manage (or to treat) the explosive rise in SARS-CoV-2 patients, but also to reduce disease While it is recognized that the discontinuation of fertility services is necessary at present, it is essential that every effort be made to continue all reproductive health services to the extent possible. Women need ongoing access to safe and reliable contraception of their choice, management of sexually transmitted infections, and, when necessary, safe termination of pregnancy. It is also a concern that there have been reports of increased gender-based violence in some communities during lockdown. We need to be especially vigilant about this particular problem at this time. To ensure safe practice and to minimize the risks related to SARS-COV-2 to our patients and staff, we must proceed cautiously as we resume treating patients. Future reproductive care will have to account for the 'new normal,' with acknowledgment that infertility care must evolve as we unravel this inscrutable disease. 

ESHRE guidance on recommencing ART treatments

American Society for Reproductive Medicine (ASRM) Patient Management and Clinical Recommendations During the Coronavirus (COVID-19) Pandemic Update #3

American Society for Reproductive Medicine (ASRM) Patient Management and Clinical Recommendations During the Coronavirus (COVID-19) Pandemic Update #2

American Society for Reproductive Medicine (ASRM) Patient Management and Clinical Recommendations During the Coronavirus (COVID-19) Pandemic Update #1